HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Muhammed D Al-Jarrah Selected Research

Probenecid (Benemid)

2/2022Endurance exercise training suppresses myostatin upregulation and nuclear factor-kappa B activation in a mouse model of Parkinson's disease.
1/2021Endurance exercise training suppresses Parkinson disease-induced overexpression of apoptotic mediators in the heart.
10/2018Interleukin-1 Beta and Tumor Necrosis Factor Alpha Upregulation and Nuclear Factor Kappa B Activation in Skeletal Muscle from a Mouse Model of Chronic/Progressive Parkinson Disease.
8/2018Association of Parkinson Disease Induction with Cardiac Upregulation of Apoptotic Mediators P53 and Active Caspase-3: An Immunohistochemistry Study.
1/2018Treadmill exercise training could attenuate the upregulation of Interleukin-1 beta and tumor necrosis factor alpha in the skeletal muscle of mouse model of chronic/progressive Parkinson disease.
1/2017Parkinson disease-induced upregulation of apoptotic mediators could be attenuated in the skeletal muscle following chronic exercise training.
1/2011Effect of endurance exercise training on the expression of GFAP, S100B, and NSE in the striatum of chronic/progressive mouse model of Parkinson's disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Muhammed D Al-Jarrah Research Topics

Disease

7Parkinsonian Disorders (Parkinsonism)
02/2022 - 01/2011
6Parkinson Disease (Parkinson's Disease)
02/2022 - 01/2017
1Muscular Atrophy (Muscle Atrophy)
02/2022
1Cardiomyopathies (Cardiomyopathy)
01/2021
1Atrophy
10/2018
1Diabetes Mellitus
02/2014
1Traumatic Brain Injuries (Traumatic Brain Injury)
01/2009

Drug/Important Bio-Agent (IBA)

71- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA
02/2022 - 01/2011
7Probenecid (Benemid)FDA LinkGeneric
02/2022 - 01/2011
3Caspase 3 (Caspase-3)IBA
01/2021 - 01/2017
2NF-kappa B (NF-kB)IBA
02/2022 - 10/2018
2Interleukin-1beta (Interleukin 1 beta)IBA
10/2018 - 01/2018
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
10/2018 - 01/2018
1MyostatinIBA
02/2022
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
02/2014

Therapy/Procedure

1Therapeutics
01/2009